Patent · US Active

Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors

US7427625B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Peter J. Connolly · New Providence, US
Stuart Emanuel · Doylestown, US
Stuart Hayden · Manalapan, US
Sigmond Johnson · Flemington, US
Bharat Lagu · Maywood, US
Steven A. Middleton · Flemington, US
Niranjan B. Pandey · White Marsh, US
Mark Powell · Burlingame, US

Key dates

Filing date	Feb 7, 2007
Grant date	Sep 23, 2008
Priority date	—
Expiry date	Feb 7, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/06
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention is directed to substituted thiatriazaacenaphthylene-6-carbonitrile compounds of formula (I):and forms thereof, their synthesis and use for treating, preventing or ameliorating a chronic or acute protein kinase mediated disease, disorder or condition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.